Quantic School of Business and Technology’s Post

🔶 Revolutionizing Pharma with AI Agents 🔶 AI is reshaping the pharmaceutical industry, and the impact is phenomenal! Imagine slashing drug discovery timelines from years to months, enabling truly personalized medicine, and enhancing clinical trials and regulatory compliance – all with AI agents. From speeding up R&D to optimizing supply chains, AI is here to streamline operations, reduce costs, and improve patient care worldwide. As a pharma professional exploring AI, I’m excited to bring these insights to life and drive real value this month. Here’s to transforming healthcare, one algorithm at a time! #AIinPharma #HealthcareInnovation #FutureOfPharma #PIAIC #PharmaTransformation #langgraph #langchain #AIagents #AIHealthcare #HealthCare #LinkedIn #EnterpriseMinds Enterprise Minds, Inc #Explore #Trending #USA #AICompanies #ExploreFeed

Imagine a new technology that could revolutionize clinical trials and the development of pharmaceutical products, one that could make it faster to safely bring patient treatments to market. The healthcare industry is on the cusp of transformation thanks to recent advances in AI. In this new paper by Keystone’s Mary Scarpulla, Aseem Mahajan, and Monika Pichler, in collaboration with Keystone expert Luba Greenwood, J.D. and Keystone alumna Colleen Carroll, we explore the technological advancements that have enabled the advent of advanced analytical tools in the healthcare space that paved the way for Digital Twin technology, and the nuances global regulators must navigate to facilitate adoption while ensuring patient safety. Click here to read more: https://bit.ly/4fvKPd3 #AI #DigitalTwins #HealthcareInnovation #DrugDevelopment #ClinicalTrials #Pharma #Technology #FutureOfMedicine

As analysts forecast a staggering surge in business spending on AI, projected to reach a whopping $300 billion by 2026, it's evident that the transformative power of AI is poised to reshape industries far and wide. Among the sectors primed for significant disruption, healthcare and the pharmaceutical industry stand out as frontrunners, with AI heralding a new era of innovation and efficiency. For more information, click here: https://bit.ly/3xhjF7U #PharmaTimes #AI #Healthcare #PharmaIndustry

As analysts forecast a staggering surge in business spending on AI, projected to reach a whopping $300 billion by 2026, it's evident that the transformative power of AI is poised to reshape industries far and wide. Among the sectors primed for significant disruption, healthcare and the pharmaceutical industry stand out as frontrunners, with AI heralding a new era of innovation and efficiency. For more information, click here: https://bit.ly/3xhjF7U #PharmaTimes #AI #Healthcare #PharmaIndustry

Postmarketing requirements (PMRs) for drug development are commonly required to gather data on a product’s longer-term safety, efficacy and optimal use. Carefully applied AI and machine learning offers the potential for better management of PMRs. Learn more from Alexandre Malouvier in our article in PharmaVoice. https://ow.ly/bMyB50TT56Y #pharma #healthcare #clinicalresearch

AI can have a very real impact on reducing risk, mitigating time delays, and ultimately saving money in drug development. If you like this, read the more detailed white paper!

🔍 Explainable AI (XAI): Shaping the Future of Pharmaceuticals with Transparency and Trust In the fast-evolving world of pharmaceuticals, AI is unlocking groundbreaking possibilities—from accelerating drug discovery to enhancing patient care. Yet, as these advanced models become more complex, they bring challenges around transparency and regulatory compliance. Enter Explainable AI (XAI)—the tool that brings clarity to AI’s decision-making, with techniques like SHAP and LIME transforming intricate algorithms into understandable insights that meet FDA and EMA standards. At PharmEng Technology, we’re committed to bridging the gap between powerful AI and the transparency needed to stay regulatory-ready. By adopting XAI, we help pharmaceutical and healthcare organizations leverage AI responsibly—fostering trust, advancing innovation, and ensuring compliance every step of the way. 🌐 𝐑𝐞𝐚𝐝𝐲 𝐭𝐨 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦 𝐀𝐈 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚? 📩 𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐮𝐬 𝐚𝐭 𝐢𝐧𝐟𝐨.𝐚𝐬𝐢𝐚@𝐩𝐡𝐚𝐫𝐦𝐞𝐧𝐠.𝐜𝐨𝐦 𝐨𝐫 𝐬𝐜𝐡𝐞𝐝𝐮𝐥𝐞 𝐚 𝐟𝐫𝐞𝐞 𝐚𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭 𝐚𝐭 https://lnkd.in/gzCy4X95 𝐭𝐨 𝐞𝐱𝐩𝐥𝐨𝐫𝐞 𝐡𝐨𝐰 𝐗𝐀𝐈 𝐜𝐚𝐧 𝐞𝐦𝐩𝐨𝐰𝐞𝐫 𝐲𝐨𝐮𝐫 𝐨𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐭𝐨 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐞 𝐰𝐢𝐭𝐡 𝐜𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐜𝐞 𝐚𝐧𝐝 𝐜𝐥𝐚𝐫𝐢𝐭𝐲. 📖 Discover more about XAI’s role in regulatory compliance, patient safety, and the future of AI-driven medicine 👉 https://lnkd.in/g2MGyHHW #PharmEngTechnology #ExplainableAI #PharmaceuticalInnovation #AIinPharma #RegulatoryCompliance #TransparentAI #HealthcareTech #AICompliance #DrugDiscovery #TrustworthyAI

This article explores the transformative impact of pharmaceutical technology (PharmaTech) on modern medicine. It highlights how advancements like AI, machine learning, and personalized medicine are revolutionizing drug discovery, development, and patient care. The piece also delves into the rise of biopharmaceuticals and advanced manufacturing techniques, while discussing the opportunities and challenges that lie ahead as PharmaTech continues to shape the future of healthcare. #PharmaceuticalTechnology #Technology #GlobalTechAwards #Awards #TechAwards #Websites #WebAwards #MobileApps #MobileAppAwards #AppAwards #Apps #Tech #PharmaTech https://lnkd.in/gazNnyCB

Postmarketing requirements (PMRs) for drug development are commonly required to gather data on a product’s longer-term safety, efficacy and optimal use. Carefully applied AI and machine learning offers the potential for better management of PMRs. Learn more from Alexandre Malouvier in our article in PharmaVoice. https://ow.ly/bMyB50TT56Y #pharma #healthcare #clinicalresearch

The healthcare industry faces chronic disease management, escalating costs, regulatory issues, and staffing shortages. Embracing technologies like Generative AI is crucial for addressing these challenges and improving efficiency, patient outcomes, and cost-effectiveness. Generative AI, through advanced data analytics and machine learning, can enhance diagnostic accuracy, personalize treatment plans, and optimize resource allocation. Read more here: https://lnkd.in/eDRWQ5Zb #BiotechPharma #Biotech #pharmaceutical #pharma #healthcare #medicine #BostonBioPharmaConsultants #marketing